Community-based naloxone: A Canadian pilot program

CJAM Canadian Journal of Addiction Medicine

Volumn 3, Issue 2, 2012, Pages 4-9

  Dong, Kathryn A ^a,b   Taylor, Marliss ^b,c   Wild, Cameron T ^a,b,c   Villa Roel, Cristina ^a   Rose, Mat ^a,b,d   Salvalaggio, Ginetta ^a,b   Rowe, Brian H ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Edmonton Inner City Health Research and Education Network   (Canada)

^c Streetworks Needle Exchange Program   (Canada)

^d Boyle McCauley Health Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG FATALITY; DRUG OVERDOSE; DRUG PROGRAM; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; DRUG USE; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PILOT STUDY; RISK REDUCTION;

EID: 84872781236     PISSN: 19231210     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Patra J, Taylor B, Rehm JT, Baliunas D, Popova S. Substanceattributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period. Can J Public Health 2007;98(3):228-34.
2. Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs 2007;68(6):886-95.
3. Popova S, Rehm J, Fischer B. An overview of illegal opioid use and health services utilization in Canada. Public Health 2006;120(4):320-8.
4. Fischer B, Rehm J, Goldman B, Popova S. Non-medical use of prescription opioids and public health in Canada: an urgent callfor research and interventions development. Can J Public Health 2008;99(3):182-4.
5. Currie CL, Schopflocher DP, Wild TC. Prevalence and correlates of 12-month prescription drug misuse in Alberta. Can J Psychiatry 2011;56(1):27-34.
6. Hsu W, Rao RB, Nelson LS. Naloxone hazards overstated. J Toxicol Clin Toxicol 1997;35(2):215-7.
7. Sporer KA, Kral KH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007;49(2):172-7.
8. Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction 2005;100(12):1823-31.
9. Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 2005;82(2):303-11.
10. Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010;21(3):186-93.
11. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009;20(2):131-6.
12. Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008;43(7):858-70.
13. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006;25(3):89-96.
14. Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ 2001;322(7291):895-6.
15. Simini B. Naloxone supplied to Italian heroin addicts. Lancet 1998;352:1.
16. Bazazi AR, Zaller ND, Fu JJ, Rich JD. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved 2010;21(4):1108-13.
17. Tobin KE, Gaasch WR, Clarke C, MacKenzie E, Latkin CA. Attitudes of Emergency Medical Service providers towards naloxone distribution programs. J Urban Health 2005;82(2):296-302.
18. Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008;103(6):979-89.
19. Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008;103(10):1648-57.
20. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. Responses to overdose. Addiction 1996;91(3):413-7.
21. Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction 1999;94(2):199-204.
22. Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health 2003;80(2):291-301.
23. Dong K. Characterizing Opioid Overdoses in Alberta [thesis]. Edmonton, AB: University of Alberta, 2007.
24. Sherman GS, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy 2009;20(2):137-42.
25. Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Alberta T. Cost effectiveness of Streetworks' needle exchange program of Edmonton. Can J Public Health 1999;90(3):168-71.
26. McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998;93(5):701-11